UK NICE recommends Eli Lilly's ALIMTA as maintenance therapy for nonsquamous NSCLC

Links shared publicly online about this topic.

  • 1,271
    total visits

UK NICE recommends Eli Lilly's ALIMTA as maintenance therapy for nonsquamous NSCLC

news-medical.net —

Eli Lilly and Company announced today that its chemotherapy ALIMTA® (pemetrexed for injection) received a positive "Final Appraisal Determination" from the United Kingdom's National Institute for Health and Clinical Excellence (NICE).

View full resource at news-medical.net

Tags: Chemotherapy, Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer Medication, Alimta, Eli Lilly and Company, Oncology

  • Share

Most Recently Shared on April 2, 2010 at 6:50 am By:

Lung_Cancer_ News-Medical.Net

Lung Cancer News: UK NICE recommends Eli Lilly's ALIMTA as maintenance therapy for nonsquamous NSCLC: Eli Lilly an... http://bit.ly/9aUs44

2 years ago...

Reply

Retweet

Favorite

Also Shared By:

News-Medical.Net News-Medical.Net

News-Medical.Net News-Medical.Net

Advertisement